Would you order an OncoType DX test on a <50 year old woman with T2 N1mi HR+ HER2- breast cancer?
1 Answers
Mednet Member
Medical Oncology · NYU Winthrop Hospital
Yes.
The patient will need chemotherapy as per RxPonder Trial.
Yes.
The patient will need chemotherapy as per RxPonder Trial.